The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia

V de Haas, WB Breunis, R Dee, OJHM Verhagen, W Kroes, ER van Wering, Jacques Dongen, H (Henk) van den Berg, CE van der Schoot

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)87-93
Number of pages7
JournalBritish Journal of Haematology
Publication statusPublished - 2002

Research programs

  • EMC MM-02-72-03

Cite this